scispace - formally typeset
H

Hao Zhang

Researcher at Shanghai Jiao Tong University

Publications -  454
Citations -  8176

Hao Zhang is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 38, co-authored 382 publications receiving 6192 citations. Previous affiliations of Hao Zhang include National Health and Family Planning Commission & Soochow University (Suzhou).

Papers
More filters
Journal ArticleDOI

Chemically activating MoS2 via spontaneous atomic palladium interfacial doping towards efficient hydrogen evolution.

TL;DR: P palladium is added into MoS2 materials to activate and stabilize the conductive basal plane to improve the electrocatalytic activity and open the possibility of manipulating the catalytic performance ofMoS2 to rival platinum.
Journal ArticleDOI

Feasibility, limitation and possible solutions of RNAi-based technology for insect pest control.

TL;DR: Current progress has proven that RNAi technology has the potential to be a tool for designing a new generation of insect control measures, and further study on dsRNA uptake mechanisms based on the knowledge of insect physiology and biochemistry is needed.
Journal ArticleDOI

In Vitro Effects of Low-Level Laser Irradiation for Bone Marrow Mesenchymal Stem Cells: Proliferation, Growth Factors Secretion and Myogenic Differentiation

TL;DR: The aim of this study was to investigate the influence of LLLI at different energy densities on BMSCs proliferation, secretion and myogenic differentiation.
Journal ArticleDOI

Second-Generation Sequencing Supply an Effective Way to Screen RNAi Targets in Large Scale for Potential Application in Pest Insect Control

TL;DR: It is demonstrated that dsRNAs are able to penetrate the integument and cause larval developmental stunt and/or death in a lepidopteron insect and largely broadens the target selection for RNAi from just gut-specific genes to the targets in whole insects.
Journal ArticleDOI

An unexpected N-terminal loop in PD-1 dominates binding by nivolumab

TL;DR: The complex structure of nivolumab withPD-1 is reported and the effects of PD-1 N-glycosylation on the interactions with nivlumab are evaluated to provide the basis for the design of future inhibitory molecules targeting PD- 1.